U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Abnormally prominent line of Schwalbe

MedGen UID:
349492
Concept ID:
C1862376
Finding
Synonym: Prominent Schwalbe line
 
HPO: HP:0007873

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVAbnormally prominent line of Schwalbe

Conditions with this feature

Axenfeld-Rieger anomaly with partially absent eye muscles, distinctive face, hydrocephaly, and skeletal abnormalities
MedGen UID:
349489
Concept ID:
C1862373
Disease or Syndrome
Axenfeld-Rieger syndrome type 1
MedGen UID:
811487
Concept ID:
C3714873
Disease or Syndrome
Axenfeld-Rieger syndrome is an autosomal dominant disorder of morphogenesis that results in abnormal development of the anterior segment of the eye, and results in blindness from glaucoma in approximately 50% of affected individuals (Fitch and Kaback, 1978). Systemic anomalies are associated, including dental hypoplasia, failure of involution of periumbilical skin, and maxillary hypoplasia (Alkemade, 1969). Genetic Heterogeneity of Axenfeld-Rieger Syndrome Linkage studies indicate that a second type of Axenfeld-Rieger syndrome maps to chromosome 13q14 (RIEG2; 601499). A third form of Axenfeld-Rieger syndrome (RIEG3; 602482) is caused by mutation in the FOXC1 gene (601090) on chromosome 6p25. See 109120 for a form of Axenfeld-Rieger syndrome associated with partially absent eye muscles, hydrocephalus, and skeletal abnormalities.

Recent clinical studies

Etiology

Roberts DK, Flynn MF, Gable EM
Optom Vis Sci 2001 Mar;78(3):133-41. doi: 10.1097/00006324-200103000-00004. PMID: 11327673
Dietlein TS, Jacobi PC, Krieglstein GK
Ger J Ophthalmol 1996 Nov;5(6):439-42. PMID: 9479533
Hartnett ME, Gilbert MM, Richardson TM, Krug JH Jr, Hirose T
Ophthalmology 1990 Jan;97(1):122-30. doi: 10.1016/s0161-6420(90)32637-4. PMID: 2314833

Diagnosis

Jacobson A, Bohnsack BL
J AAPOS 2022 Dec;26(6):320-322. Epub 2022 Sep 22 doi: 10.1016/j.jaapos.2022.08.263. PMID: 36152758
Espinosa-Barberi G, Galván González JF, Antón A
Rom J Ophthalmol 2020 Oct-Dec;64(4):455-458. doi: 10.22336/rjo.2020.70. PMID: 33367186Free PMC Article
Roberts DK, Flynn MF, Gable EM
Optom Vis Sci 2001 Mar;78(3):133-41. doi: 10.1097/00006324-200103000-00004. PMID: 11327673
Ozeki H, Shirai S, Ikeda K, Ogura Y
Graefes Arch Clin Exp Ophthalmol 1999 Sep;237(9):730-4. doi: 10.1007/s004170050304. PMID: 10447647
Shields MB
Trans Am Ophthalmol Soc 1983;81:736-84. PMID: 6676983Free PMC Article

Prognosis

Dietlein TS, Jacobi PC, Krieglstein GK
Ger J Ophthalmol 1996 Nov;5(6):439-42. PMID: 9479533
Hartnett ME, Gilbert MM, Richardson TM, Krug JH Jr, Hirose T
Ophthalmology 1990 Jan;97(1):122-30. doi: 10.1016/s0161-6420(90)32637-4. PMID: 2314833

Clinical prediction guides

Espinosa-Barberi G, Galván González JF, Antón A
Rom J Ophthalmol 2020 Oct-Dec;64(4):455-458. doi: 10.22336/rjo.2020.70. PMID: 33367186Free PMC Article
Grosso S, Farnetani MA, Berardi R, Vivarelli R, Vanni M, Morgese G, Balestri P
Am J Med Genet 2002 Aug 1;111(2):182-6. doi: 10.1002/ajmg.10493. PMID: 12210347
Ozeki H, Shirai S, Ikeda K, Ogura Y
Graefes Arch Clin Exp Ophthalmol 1999 Sep;237(9):730-4. doi: 10.1007/s004170050304. PMID: 10447647
Dietlein TS, Jacobi PC, Krieglstein GK
Ger J Ophthalmol 1996 Nov;5(6):439-42. PMID: 9479533
Tawara A, Inomata H
Jpn J Ophthalmol 1983;27(1):63-72. PMID: 6855021

Supplemental Content

Table of contents

    Clinical resources

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...